Hemab Therapeutics Holdings, Inc. (COAG) stock
Close on Nov 13, 2026Market cap $1.91BP/E –Yield –
Hemab Therapeutics statistics
36 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 4.45
- 2.22
Share statisticsIndustry
- Float
- 38M
- 49M
- Shares Held by Insiders
- 19.5%
- 11.6%
- Shares Held by Institutions
- 77.5%
- 56.4%
Short sellingIndustry
- Short Interest
- 3M
- –
- Short Interest Change
- 4.56%
- -0.80%
- Short % of Float
- 8.79%
- 8.98%
- Short % of Shares Outstanding
- 7.08%
- 6.30%
- Days to Cover
- 7.31
- 5.16
Stock price statisticsIndustry
- 20-Day Moving Average
- $39.54
- –
- 50-Day Moving Average
- $37.05
- –
- Average True Range (14)
- $3.56
- –
- Price Change (1 Week)
- -16.6%
- -1.15%
- Price Change (1 Month)
- 25.6%
- -4.86%
- Price Change (3 Months)
- -23.8%
- -21.1%
- Price Change (6 Months)
- 45.6%
- -20.7%
- Average Volume (10 Days)
- 559,016
- –
- Average Volume (20 Days)
- 514,782
- –
- Average Volume (90 Days)
- 466,751
- –
- Relative Volume
- 0.86
- 0.70
- Relative Strength Index (14)
- 54.0
- 43.4
- Volatility (1 Year)
- 88.2%
- 80.1%
Financial positionIndustry
- Current Ratio
- 33.86
- 3.30
- Quick Ratio
- 33.25
- 2.39
Balance sheetIndustry
- Net Cash (Debt)
- $430.24M
- $17.80M
- Net Cash Per Share
- $9.21
- $0.80
- Equity (Book Value)
- $429.27M
- $53.27M
- Book Value Per Share
- $9.19
- $1.50
- Tangible Book Value
- $429.27M
- $26.82M
- Working Capital
- $425.22M
- $79.93M
Scores and fair valueIndustry
- Altman Z-Score
- 85.53
- 0.23
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | COAG | S&P 500 | Difference | COAG per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +37.1% | -3.0% | +40.2 pts | ||
| 3 months | -24.3% | -2.8% | −21.5 pts |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
3M COAG shares were sold short on Oct 30, 2026, up 4.6% from the previous report, or 8.79% of the shares available to trade. At recent volumes it would take 7.3 days to buy them back. Over the last 20 sessions, 57.3% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 3,305,474 | +4.6% | 451,955 | 7.3 |
| Oct 15, 2026 | 3,161,285 | -6.8% | 404,790 | 7.8 |
| Sep 30, 2026 | 3,390,130 | +28.4% | 811,205 | 4.2 |
| Sep 15, 2026 | 2,641,038 | +25.3% | 350,112 | 7.5 |
| Aug 31, 2026 | 2,107,998 | +3.7% | 349,480 | 6.0 |
| Aug 14, 2026 | 2,032,688 | -0.3% | 330,066 | 6.2 |
| Jul 31, 2026 | 2,038,062 | +22.9% | 479,211 | 4.3 |
| Jul 15, 2026 | 1,658,857 | -3.3% | 311,224 | 5.3 |
| Jun 30, 2026 | 1,714,796 | +26.6% | 423,786 | 4.0 |
| Jun 15, 2026 | 1,354,937 | +32.0% | 179,441 | 7.5 |
| May 29, 2026 | 1,026,514 | +35.3% | 158,083 | 6.5 |
| May 15, 2026 | 758,697 | – | 622,622 | 1.2 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?